KimSMWatersPWoodhallM. Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders. Mult Scler2013; 19: 1060–1067.
2.
LennonVAKryzerTJPittockSJ. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin 4 water channel. J Exp Med2005; 202: 473–477.
3.
PapadopoulosMCVerkmanAS. Aquaporin 4 and neuromyelitis optica. Lancet Neurol2012; 11: 535–544.
4.
WeinshenkerBG. Neuromyelitis optica is distinct from multiple sclerosis. Arch Neurol2007; 64: 899–901.
5.
WatersPJMcKeonALeiteMI. Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays. Neurology2012; 78: 665–671.
6.
JariusSWandingerKPBorowskiK. Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: Case report and review of the literature. Clin Neurol Neurosurg2012; 114: 331–335.
7.
WingerchukDMLennonVALucchinettiCF. The spectrum of neuromyelitis optica. Lancet Neurol2007; 6: 810–815.
